| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/17/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $88.66 | $110.8k | | 05/17/2023 |
| 05/17/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 05/17/2023 |
| 03/17/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 03/17/2023 |
| 03/17/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $64.03 | $80k | | 03/17/2023 |
| 01/17/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $52.42 | $65.5k | | 01/17/2023 |
| 01/17/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 01/17/2023 |
| 01/01/2023 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 3.9k | $0.00 | $0 | | 01/01/2023 |
| 01/01/2023 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 7.4k | $51.71 | $384.8k | | 01/01/2023 |
| 12/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $52.35 | $65.4k | | 12/15/2022 |
| 12/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 12/15/2022 |
| 11/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $48.01 | $60k | | 11/15/2022 |
| 11/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 11/15/2022 |
| 10/14/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $59.31 | $74.1k | | 10/14/2022 |
| 10/14/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 10/14/2022 |
| 09/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $66.00 | $82.5k | | 09/15/2022 |
| 09/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 09/15/2022 |
| 08/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $67.21 | $84k | | 08/15/2022 |
| 08/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 08/15/2022 |
| 07/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $46.33 | $57.9k | | 07/15/2022 |
| 07/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 07/15/2022 |
| 06/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $39.29 | $49.1k | | 06/15/2022 |
| 06/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 06/15/2022 |
| 05/16/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $39.18 | $49k | | 05/16/2022 |
| 05/16/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 05/16/2022 |
| 04/14/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $50.90 | $63.6k | | 04/14/2022 |
| 04/14/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 04/14/2022 |
| 03/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $39.57 | $49.5k | | 03/15/2022 |
| 03/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock option (right to buy) | 1.2k | $2.67 | $3.3k | | 03/15/2022 |
| 02/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $45.43 | $56.8k | | 02/15/2022 |
| 02/15/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 1.2k | $2.67 | $3.3k | | 02/15/2022 |
| 01/14/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Common Stock | 1.2k | $2.67 | $3.3k | | 01/14/2022 |
| 01/14/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $40.56 | $50.7k | | 01/14/2022 |
| 01/14/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option(Right to Buy) | 1.2k | $2.67 | $3.3k | | 01/14/2022 |
| 01/01/2022 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 4.2k | $0.00 | $0 | | 01/01/2022 |
| 01/01/2022 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 8.6k | $47.28 | $404.4k | | 01/01/2022 |
|